Nodal marginal zone lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
== Overview == | == Overview == | ||
== Pathophysiology== | == Pathophysiology== | ||
| Line 25: | Line 21: | ||
==Causes== | ==Causes== | ||
There are no established causes for nodal marginal zone lymphoma. | |||
==Differentiating type page name here from other Diseases== | ==Differentiating type page name here from other Diseases== | ||
| Line 157: | Line 27: | ||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
===Age=== | ===Age=== | ||
The incidence of nodal marginal zone lymphoma increases with age; the median age at diagnosis is 60 years. | |||
===Gender=== | ===Gender=== | ||
Females are more commonly affected with nodal marginal zone lymphoma than males. | |||
== Risk Factors == | == Risk Factors == | ||
There are no established risk factors for nodal marginal zone lymphoma. | |||
== Screening == | == Screening == | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for nodal marginal zone lymphoma. | |||
== Natural History, Complications and Prognosis== | == Natural History, Complications and Prognosis== | ||
Nodal marginal zone lymphoma is often slow growing (indolent). However, it can change (transform) into a more aggressive large cell lymphoma. Nodal marginal zone lymphomas behave slightly more aggressively than [[MALT lymphoma]]s. | |||
== Diagnosis == | == Diagnosis == | ||
| Line 176: | Line 46: | ||
=== Symptoms === | === Symptoms === | ||
=== Physical Examination === | === Physical Examination === | ||
| Line 274: | Line 128: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Oncology]] | |||
Revision as of 15:25, 4 March 2016
For patient information, click Insert page name here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Synonyms and keywords:: NMZL; Nodal marginal zone B cell lymphoma; Monocytoid B-cell lymphoma; Nodal monocytoid B-cell lymphoma
Overview
Pathophysiology
Genetics
Associated Conditions
Gross Pathology
Microscopic Pathology
Causes
There are no established causes for nodal marginal zone lymphoma.
Differentiating type page name here from other Diseases
Epidemiology and Demographics
Age
The incidence of nodal marginal zone lymphoma increases with age; the median age at diagnosis is 60 years.
Gender
Females are more commonly affected with nodal marginal zone lymphoma than males.
Risk Factors
There are no established risk factors for nodal marginal zone lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for nodal marginal zone lymphoma.
Natural History, Complications and Prognosis
Nodal marginal zone lymphoma is often slow growing (indolent). However, it can change (transform) into a more aggressive large cell lymphoma. Nodal marginal zone lymphomas behave slightly more aggressively than MALT lymphomas.
Diagnosis
Diagnostic Criteria
If available, the diagnostic criteria are provided here.
History
A directed history should be obtained to ascertain